Localization of the Angiotensin II Receptor Subtypes in the Human Atrium
Angiotensin II has two major receptor subtypes, designated AT 1and AT 2. Both have been detected in the heart of several species, but most of the known functions of angiotensin II seem to be mediated through the AT 1receptor. The major objective of this study was to specify the cell type on which th...
Gespeichert in:
Veröffentlicht in: | Journal of molecular and cellular cardiology 1996-08, Vol.28 (8), p.1789-1799 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Angiotensin II has two major receptor subtypes, designated AT
1and AT
2. Both have been detected in the heart of several species, but most of the known functions of angiotensin II seem to be mediated through the AT
1receptor. The major objective of this study was to specify the cell type on which the AT
2receptor is located in the atrium of human heart. Right atrial biopsies from patients with coronary artery disease were tested in membrane binding assays and found to contain high levels of angiotensin II receptor (820±175 fmol/mg), 82±2% of which was of the AT
2subtype. Cryostat sections of these biopsies were incubated with
125I-[Sar
1,Ile
8] angiotensin II in the presence of selective concentrations of the cold ligands losartan and CGP 42112A to detect the subtypes using microscopic autoradiography. High local densities of the AT
2receptor were observed. Comparison of the labelling patterns thus obtained with adjacent sections stained for vimentin, collagen, neurofilaments or acetylcholinesterase revealed that the high densities of AT
2receptor were always associated with fibrous tissue. However, the AT
1receptor was in general evenly distributed over the tissue at low concentrations. Higher local concentrations of this receptor subtype were observed on nervous tissue. The present finding of high densities of the AT
2receptor on fibroblasts at sites of fibrosis may have important clinical implications. Further studies to elucidate the function of this receptor subtype in the heart are therefore essential and the clinical consequences of the use of AT
1antagonists on post-infarction remodelling should be investigated. |
---|---|
ISSN: | 0022-2828 1095-8584 |
DOI: | 10.1006/jmcc.1996.0168 |